Back to News
Market Impact: 0.25

Air Force begins testing mission autonomy package for CCA prototypes

RTX
Artificial IntelligenceTechnology & InnovationInfrastructure & DefenseGeopolitics & WarCybersecurity & Data PrivacyAntitrust & CompetitionProduct Launches

The Air Force is integrating and testing a government-owned Autonomy Government Reference Architecture (A-GRA) and mission-autonomy software on Collaborative Combat Aircraft (CCA) prototypes from General Atomics (YFQ-42A) and Anduril (YFQ-44A), with Collins Aerospace and Shield AI contracted to provide autonomy solutions and conduct semi-autonomous flight tests. The program — part of the NGAD family and structured in spiral increments — expects an Increment 1 production decision this year and has signaled intent to procure at least 1,000 Increment 1 drones to begin fielding before the end of the decade, a development that could benefit defense contractors and autonomy-software vendors while preserving a modular, competitive ecosystem.

Analysis

Market structure: Short-term winners are Collins Aerospace (RTX ticker) and autonomy software vendors (Shield AI, Anduril/General Atomics platforms) because RTX captures systems-integration and A‑GRA IP; program scale (DoD target ≥1,000 Increment‑1 CCAs) implies a hardware+software TAM of roughly $3–6B upfront and $200–500M/year sustainment over a decade if unit costs are $3–6M and S/W/integration take 10–20% of spend. Incumbent platform-centric primes face pricing pressure long‑term because A‑GRA reduces vendor lock and commoditizes autonomy stacks, shifting margin pool toward integrators and algorithm vendors. Risk assessment: Key tail risks include a high‑visibility software failure or cyber compromise that could delay production >12 months (estimate 5–15% probability), or Congressional/DoD reprioritization that cuts procurement (10–20%). Hidden dependencies: CCA value hinges on secure sensor, compute, and chip supply chains (COTS SOCs, RTX sensors) and certification throughput; delays in chip availability or testing capacity would push fielding past 2029. Near‑term catalysts: public semi‑autonomous demos (30–90 days), formal Increment‑1 production award (by year‑end 2026), and FY‑2027 DoD budget decisions. Trade implications: Tactical: establish a 2–3% long position in RTX ahead of the production decision expected by Q4 2026; hedge program execution risk with a financed call spread — buy Jul‑2026 3–5% OTM calls and sell Jul‑2026 12–15% OTM calls sized to limit cost to <1% NAV. Relative value: long RTX vs short LOCKHEED (LMT) 1:1 small size (0.5–1% NAV) to express premium to systems integrators over pure airframe integrators. Manage exits: trim half on +8–12% move or cut at -8% on adverse test/program news. Contrarian angles: Consensus sees autonomy as uniformly pro‑innovation; market underestimates that open A‑GRA may compress long‑term margins for platform OEMs and create recurring service revenue for systems integrators — favoring RTX/LHX over LMT/NOC in multi‑year buckets. Historical parallel: modularization of avionics (akin to past COTS waves) initially boosts integrators then forces price competition; unintended consequences include stricter export/AI controls and liability rules that could halve TAM in some international markets, a scenario to stress‑test before increasing position sizes.